17 results on '"Avola, Giuseppe"'
Search Results
2. Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy
3. Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma
4. Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma
5. Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma.
6. Acute GVHD after allogeneic hematopoietic transplantation affects early marrow reconstitution and speed of engraftment
7. Gvhd-Associated Early Impairment of Marrow Function Is Frequent after Allogeneic Transplantation and Is a Sensitive Biomarker for Prediction of Treatment Related Mortality and of Overall Survival
8. In AML patients treated by allogeneic hematopoietic transplantation, CD34+ supermobilization is a negative prognostic factor
9. Chemosensitivity of nonleukemic clonogenic precursors in AML patients in complete remission: Association with CD34+ mobilization and with disease-free survival
10. AML Patients In First CR with Intermediate Risk Cytogenetic and High Level of CD34+ Mobilization Have Better DFS After Allogeneic Transplantation.
11. Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy
12. Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.
13. Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than cyclophosphamide 4 g/m2plus G-CSF 10 g/kg in PBSC mobilization of lymphoma patients
14. Expression profile and specific network featuresof the apoptotic machinery explain relapse ofacute myeloid leukemia after chemotherapy.
15. Intermediate dose etoposide plus G-CSF 16 g/kg is more effective than cyclophosphamide 4 g/m2 plus G-CSF 10 g/kg in PBSC mobilization of lymphoma patients.
16. High Level of IL-2-Receptor and of TIM-3 in Plasma at Day +18 after Allogeneic Transplantation Can Identify Early Patients at Risk for Treatment Related Mortality
17. Chemosensitivity of nonleukemic clonogenic precursors in AML patients in complete remission: Association with CD34+ mobilization and with disease-free survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.